Your browser doesn't support javascript.
loading
CBX8 Together with SET Facilitates Ovarian Carcinoma Growth and Metastasis by Suppressing the Transcription of SUSD2.
Wu, Yanjie; Duan, Yang; Li, Xuanyuan; Zhao, Ran; Lan, Bei; Zhang, Xingyan; Wang, Xiaochen; Chen, Hao; Feng, Shengyun; Liu, Zhenfeng; Cheng, Yiming; Xi, Lishan; Wang, Yingmei; Xue, Fengxia; Xuan, Chenghao.
Afiliação
  • Wu Y; Tianjin Key Laboratory of Female Reproductive Health and Eugenetics, Tianjin Medical University General Hospital; the Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics; Department of Biochemistry and Molecular Biology, Tianjin Medical University, Tianjin, Chi
  • Duan Y; Clinical Laboratory, Weifang People's Hospital, Weifang, Shandong, China.
  • Li X; Tianjin Key Laboratory of Female Reproductive Health and Eugenetics, Tianjin Medical University General Hospital; the Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics; Department of Biochemistry and Molecular Biology, Tianjin Medical University, Tianjin, Chi
  • Zhao R; Tianjin Key Laboratory of Female Reproductive Health and Eugenetics, Tianjin Medical University General Hospital; the Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics; Department of Biochemistry and Molecular Biology, Tianjin Medical University, Tianjin, Chi
  • Lan B; Tianjin Key Laboratory of Female Reproductive Health and Eugenetics, Tianjin Medical University General Hospital; the Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics; Department of Biochemistry and Molecular Biology, Tianjin Medical University, Tianjin, Chi
  • Zhang X; Tianjin Key Laboratory of Female Reproductive Health and Eugenetics, Tianjin Medical University General Hospital; the Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics; Department of Biochemistry and Molecular Biology, Tianjin Medical University, Tianjin, Chi
  • Wang X; Tianjin Key Laboratory of Female Reproductive Health and Eugenetics, Tianjin Medical University General Hospital; the Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics; Department of Biochemistry and Molecular Biology, Tianjin Medical University, Tianjin, Chi
  • Chen H; Tianjin Key Laboratory of Female Reproductive Health and Eugenetics, Tianjin Medical University General Hospital; the Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics; Department of Biochemistry and Molecular Biology, Tianjin Medical University, Tianjin, Chi
  • Feng S; Tianjin Key Laboratory of Female Reproductive Health and Eugenetics, Tianjin Medical University General Hospital; the Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics; Department of Biochemistry and Molecular Biology, Tianjin Medical University, Tianjin, Chi
  • Liu Z; Tianjin Key Laboratory of Female Reproductive Health and Eugenetics, Tianjin Medical University General Hospital; the Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics; Department of Biochemistry and Molecular Biology, Tianjin Medical University, Tianjin, Chi
  • Cheng Y; Tianjin Key Laboratory of Female Reproductive Health and Eugenetics, Tianjin Medical University General Hospital; the Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics; Department of Biochemistry and Molecular Biology, Tianjin Medical University, Tianjin, Chi
  • Xi L; Tianjin Key Laboratory of Female Reproductive Health and Eugenetics, Tianjin Medical University General Hospital; the Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics; Department of Biochemistry and Molecular Biology, Tianjin Medical University, Tianjin, Chi
  • Wang Y; Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin, China.
  • Xue F; Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin, China.
  • Xuan C; Tianjin Key Laboratory of Female Reproductive Health and Eugenetics, Tianjin Medical University General Hospital; the Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics; Department of Biochemistry and Molecular Biology, Tianjin Medical University, Tianjin, Chi
Mol Cancer Res ; 20(11): 1611-1622, 2022 11 03.
Article em En | MEDLINE | ID: mdl-35894945
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Glicoproteínas de Membrana / Carcinoma / Complexo Repressor Polycomb 1 / Neoplasias Hepáticas Limite: Female / Humans Idioma: En Revista: Mol Cancer Res Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Glicoproteínas de Membrana / Carcinoma / Complexo Repressor Polycomb 1 / Neoplasias Hepáticas Limite: Female / Humans Idioma: En Revista: Mol Cancer Res Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article